Current Assets
Short-Term Investments
Gilead Sciences Short-Term Investments decreased by 77.9% to $15M in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows a downward trend with a -45.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase suggests the company is accumulating cash or seeking short-term yield, while a decrease may indicate cash usage for operations, acquisitions, or debt repayment.
Detailed definition
These are highly liquid financial instruments, such as marketable securities, that the company intends to convert into c...
Peer comparison
Biopharma companies often hold significant short-term investments to fund future R&D pipelines or potential M&A activity.
Metric ID:
short_term_investmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.38B | $1.18B | $1.03B | $924M | $961M | $973M | $936M | $963M | $1.16B | $1.18B | $0 | $0 | $0 | $0 | $69M | $19M | $68M | $15M |
| QoQ Change | — | -15.7% | -14.1% | -12.9% | -10.2% | +4.0% | +1.2% | -3.8% | +2.9% | +20.4% | +1.7% | -100.0% | — | — | — | — | -72.5% | +257.9% | -77.9% |
| YoY Change | — | — | — | — | -43.4% | -30.2% | -17.7% | -9.0% | +4.2% | +20.6% | +21.2% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — |
Range$0 – $1.63B
CAGR-64.7%
Avg YoY Growth-41.3%
Median YoY Growth-30.2%
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's short-term investments?
- Gilead Sciences (GILD) reported short-term investments of $15M in Q1 2026.
- What is the long-term trend for Gilead Sciences's short-term investments?
- Over 5 years (2020 to 2025), Gilead Sciences's short-term investments has grown at a -45.5% compound annual growth rate (CAGR), from $1.41B to $68M.
- What does short-term investments mean?
- Liquid investments that can be easily converted to cash within a year.